Report cover image

Medication for Dental Industry Research Report 2025

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 127 Pages
SKU # APRC20352526

Description

Summary

According to APO Research, The global Medication for Dental market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Medication for Dental is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Medication for Dental is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Medication for Dental is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Medication for Dental include Teva, Sun Pharmaceutical, Johnson & Johnson, Qilu Pharmaceutical, Novartis, Mylan, GSK, Bayer and Lupin, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Medication for Dental, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medication for Dental.
The Medication for Dental market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Medication for Dental market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Medication for Dental Segment by Company

Teva
Sun Pharmaceutical
Johnson & Johnson
Qilu Pharmaceutical
Novartis
Mylan
GSK
Bayer
Lupin
Lingrui
Galderma
Dr. Reddy's
CR SANJIU
Cipla
Bausch Health
Aurobindo
Almirall
Medication for Dental Segment by Type

NSAID
OTC Analgesic Medications
Opioid
Medication for Dental Segment by Application

Drug Store
Hospital
Other
Medication for Dental Segment by Application

Drug Store
Hospital
Other
Medication for Dental Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medication for Dental market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medication for Dental and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medication for Dental.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Medication for Dental companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.

Table of Contents

127 Pages
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Medication for Dental by Type
2.2.1 Market Value Comparison by Type (2020 VS 2024 VS 2031)
2.2.2 NSAID
2.2.3 OTC Analgesic Medications
2.2.4 Opioid
2.3 Medication for Dental by Application
2.3.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.3.2 Drug Store
2.3.3 Hospital
2.3.4 Other
2.4 Assumptions and Limitations
3 Medication for Dental Breakdown Data by Type
3.1 Global Medication for Dental Historic Market Size by Type (2020-2025)
3.2 Global Medication for Dental Forecasted Market Size by Type (2026-2031)
4 Medication for Dental Breakdown Data by Application
4.1 Global Medication for Dental Historic Market Size by Application (2020-2025)
4.2 Global Medication for Dental Forecasted Market Size by Application (2026-2031)
5 Global Growth Trends
5.1 Global Medication for Dental Market Perspective (2020-2031)
5.2 Global Medication for Dental Growth Trends by Region
5.2.1 Global Medication for Dental Market Size by Region: 2020 VS 2024 VS 2031
5.2.2 Medication for Dental Historic Market Size by Region (2020-2025)
5.2.3 Medication for Dental Forecasted Market Size by Region (2026-2031)
5.3 Medication for Dental Market Dynamics
5.3.1 Medication for Dental Industry Trends
5.3.2 Medication for Dental Market Drivers
5.3.3 Medication for Dental Market Challenges
5.3.4 Medication for Dental Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Medication for Dental Players by Revenue
6.1.1 Global Top Medication for Dental Players by Revenue (2020-2025)
6.1.2 Global Medication for Dental Revenue Market Share by Players (2020-2025)
6.2 Global Medication for Dental Industry Players Ranking, 2023 VS 2024 VS 2025
6.3 Global Key Players of Medication for Dental Head Office and Area Served
6.4 Global Medication for Dental Players, Product Type & Application
6.5 Global Medication for Dental Manufacturers Established Date
6.6 Global Medication for Dental Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Medication for Dental Market Size (2020-2031)
7.2 North America Medication for Dental Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 North America Medication for Dental Market Size by Country (2020-2025)
7.4 North America Medication for Dental Market Size by Country (2026-2031)
7.5 United States
7.5 United States
7.6 Canada
7.7 Mexico
8 Europe
8.1 Europe Medication for Dental Market Size (2020-2031)
8.2 Europe Medication for Dental Market Growth Rate by Country: 2020 VS 2024 VS 2031
8.3 Europe Medication for Dental Market Size by Country (2020-2025)
8.4 Europe Medication for Dental Market Size by Country (2026-2031)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Spain
8.10 Russia
8.11 Netherlands
8.12 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Medication for Dental Market Size (2020-2031)
9.2 Asia-Pacific Medication for Dental Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Asia-Pacific Medication for Dental Market Size by Country (2020-2025)
9.4 Asia-Pacific Medication for Dental Market Size by Country (2026-2031)
9.5 China
9.6 Japan
9.7 South Korea
9.8 India
9.9 Australia
9.10 China Taiwan
9.11 Southeast Asia
10 South America
10.1 South America Medication for Dental Market Size (2020-2031)
10.2 South America Medication for Dental Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 South America Medication for Dental Market Size by Country (2020-2025)
10.4 South America Medication for Dental Market Size by Country (2026-2031)
10.5 Brazil
10.6 Argentina
10.7 Chile
10.8 Colombia
10.9 Peru
11 Middle East & Africa
11.1 Middle East & Africa Medication for Dental Market Size (2020-2031)
11.2 Middle East & Africa Medication for Dental Market Growth Rate by Country: 2020 VS 2024 VS 2031
11.3 Middle East & Africa Medication for Dental Market Size by Country (2020-2025)
11.4 Middle East & Africa Medication for Dental Market Size by Country (2026-2031)
11.5 Saudi Arabia
11.6 Israel
11.7 United Arab Emirates
11.8 Turkey
11.9 Iran
11.10 Egypt
12 Players Profiled
12.1 Teva
12.1.1 Teva Company Information
12.1.2 Teva Business Overview
12.1.3 Teva Revenue in Medication for Dental Business (2020-2025)
12.1.4 Teva Medication for Dental Product Portfolio
12.1.5 Teva Recent Developments
12.2 Sun Pharmaceutical
12.2.1 Sun Pharmaceutical Company Information
12.2.2 Sun Pharmaceutical Business Overview
12.2.3 Sun Pharmaceutical Revenue in Medication for Dental Business (2020-2025)
12.2.4 Sun Pharmaceutical Medication for Dental Product Portfolio
12.2.5 Sun Pharmaceutical Recent Developments
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Company Information
12.3.2 Johnson & Johnson Business Overview
12.3.3 Johnson & Johnson Revenue in Medication for Dental Business (2020-2025)
12.3.4 Johnson & Johnson Medication for Dental Product Portfolio
12.3.5 Johnson & Johnson Recent Developments
12.4 Qilu Pharmaceutical
12.4.1 Qilu Pharmaceutical Company Information
12.4.2 Qilu Pharmaceutical Business Overview
12.4.3 Qilu Pharmaceutical Revenue in Medication for Dental Business (2020-2025)
12.4.4 Qilu Pharmaceutical Medication for Dental Product Portfolio
12.4.5 Qilu Pharmaceutical Recent Developments
12.5 Novartis
12.5.1 Novartis Company Information
12.5.2 Novartis Business Overview
12.5.3 Novartis Revenue in Medication for Dental Business (2020-2025)
12.5.4 Novartis Medication for Dental Product Portfolio
12.5.5 Novartis Recent Developments
12.6 Mylan
12.6.1 Mylan Company Information
12.6.2 Mylan Business Overview
12.6.3 Mylan Revenue in Medication for Dental Business (2020-2025)
12.6.4 Mylan Medication for Dental Product Portfolio
12.6.5 Mylan Recent Developments
12.7 GSK
12.7.1 GSK Company Information
12.7.2 GSK Business Overview
12.7.3 GSK Revenue in Medication for Dental Business (2020-2025)
12.7.4 GSK Medication for Dental Product Portfolio
12.7.5 GSK Recent Developments
12.8 Bayer
12.8.1 Bayer Company Information
12.8.2 Bayer Business Overview
12.8.3 Bayer Revenue in Medication for Dental Business (2020-2025)
12.8.4 Bayer Medication for Dental Product Portfolio
12.8.5 Bayer Recent Developments
12.9 Lupin
12.9.1 Lupin Company Information
12.9.2 Lupin Business Overview
12.9.3 Lupin Revenue in Medication for Dental Business (2020-2025)
12.9.4 Lupin Medication for Dental Product Portfolio
12.9.5 Lupin Recent Developments
12.10 Lingrui
12.10.1 Lingrui Company Information
12.10.2 Lingrui Business Overview
12.10.3 Lingrui Revenue in Medication for Dental Business (2020-2025)
12.10.4 Lingrui Medication for Dental Product Portfolio
12.10.5 Lingrui Recent Developments
12.11 Galderma
12.11.1 Galderma Company Information
12.11.2 Galderma Business Overview
12.11.3 Galderma Revenue in Medication for Dental Business (2020-2025)
12.11.4 Galderma Medication for Dental Product Portfolio
12.11.5 Galderma Recent Developments
12.12 Dr. Reddy's
12.12.1 Dr. Reddy's Company Information
12.12.2 Dr. Reddy's Business Overview
12.12.3 Dr. Reddy's Revenue in Medication for Dental Business (2020-2025)
12.12.4 Dr. Reddy's Medication for Dental Product Portfolio
12.12.5 Dr. Reddy's Recent Developments
12.13 CR SANJIU
12.13.1 CR SANJIU Company Information
12.13.2 CR SANJIU Business Overview
12.13.3 CR SANJIU Revenue in Medication for Dental Business (2020-2025)
12.13.4 CR SANJIU Medication for Dental Product Portfolio
12.13.5 CR SANJIU Recent Developments
12.14 Cipla
12.14.1 Cipla Company Information
12.14.2 Cipla Business Overview
12.14.3 Cipla Revenue in Medication for Dental Business (2020-2025)
12.14.4 Cipla Medication for Dental Product Portfolio
12.14.5 Cipla Recent Developments
12.15 Bausch Health
12.15.1 Bausch Health Company Information
12.15.2 Bausch Health Business Overview
12.15.3 Bausch Health Revenue in Medication for Dental Business (2020-2025)
12.15.4 Bausch Health Medication for Dental Product Portfolio
12.15.5 Bausch Health Recent Developments
12.16 Aurobindo
12.16.1 Aurobindo Company Information
12.16.2 Aurobindo Business Overview
12.16.3 Aurobindo Revenue in Medication for Dental Business (2020-2025)
12.16.4 Aurobindo Medication for Dental Product Portfolio
12.16.5 Aurobindo Recent Developments
12.17 Almirall
12.17.1 Almirall Company Information
12.17.2 Almirall Business Overview
12.17.3 Almirall Revenue in Medication for Dental Business (2020-2025)
12.17.4 Almirall Medication for Dental Product Portfolio
12.17.5 Almirall Recent Developments
13 Report Conclusion
14 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.